Stucture (Image 01)
Zoledronic Acid Injection, Solution
Product Images NDC 67457-794
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Zoledronic Acid (NDC 67457-794). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Mylan Institutional Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 2 (Image 02)
This appears to be a graph depicting therapeutic response over time for two different treatments, Zoledronic Acid and Risedronate, as measured by Response Rate (%), represented on the y-axis. The x-axis depicts the time in days, and the graph shows a significant improvement in response rate for both treatments over time. There is also a second graph indicating serum alkaline phosphatase (SAP) normalization rate over time, represented by a line graph. The same two treatments, Zoledronic Acid and Risedronate, are compared and show a significant improvement in SAP normalization rate over time as well.*
Pouch Label (Image 03)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
